Biosortia is doing what works in a way nobody ever thought possible or scalable. By providing target-hitting small molecules and datasets using deep access to previously unculturable microbes and their molecules. A valuable and proven source for the future of therapeutics. Target-hitting molecules are what we need to move the needle forward in medicine today.

Using unique direct access to previously inaccessible microbial small molecules and extensive datasets accelerate discovery in critical life science areas, including new opportunities with next-generation drugs, agrochemicals, longevity, sustainability, and even the advanced energy sector.

Learn More